Cytology Brush Market

Cytology Brush Market by Product Type (Disposable & Reusable), Disease Type (Lung Cancer, Ovarian cancer, & Others), and End User (Hospitals, Ambulatory Surgical Centers, & Others) - Global Forecast to 2023

Report Code: UC 1996 May, 2024, by

Request for detailed table of content.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)

The global cytology brush market is expected to reach USD 83.1million by 2023 from USD 64.5 million in 2018, growing at a CAGR of 5.2%. Increasing awareness and demand for minimally invasive procedures, increasing incidence of cancer, and rising awareness about early diagnosis especially for cancer and are some of the major factors driving the growth of the global cytology brush market.

North America dominates the cytology brush market with the U.S. accounting for the major market share in 2017. Established healthcare infrastructure; and increasing demand for disposable instruments are some of the major driving factors driving the growth of this market in North America. The Asian cytology brush market is poised to grow at the highest CAGR during the forecast period owing to improving healthcare infrastructure and rising awareness about early diagnosis especially for cancer among people in the region. The rising focus of prominent players on the Asian cytology brush market is another factor driving its growth. Furthermore, emerging countries such as India and China provides immense growth opportunities to the cytology brush manufacturers.

Prominent players in the cytology brush market are U.S. Endoscopy (U.S.), Cook Medical (U.S.), Olympus Corporation (U.S.), Diagmed (UK), Boston Scientific (U.S.), Conmed (U.S.), Omnimed (UK), EndoChoice (U.S.), Cantel UK (UK), Thermo Fisher Scientific (U.S.), Cardinal Health (U.S.), Mil-Rose Laboratories (U.S.), and Sanderson Macleod (U.S.).

Scope of the Report

This research report covers the global cytology brush market by product type; disease type; end user; and geography.

Cytology Brush Market, by Product Type

  • Reusable
  • disposable

Cytology Brush Market, by Disease Type

  • lung Cancer
  • ovarian cancer

Cytology Brush Market, by End User

  • hospitals
  • ambulatory surgical center
  • others

Cytology Brush Market, by region

  • North america
    • US
    • Canada
  • Europe
    • germany
    • UK
    • rest of europe (roe)
  • Asia pacific
    • china
    • india
    • japan
    • rest of asia pacific
  • Rest of the world (roW)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization
Report Code
UC 1996
Available for Pre-Book
Choose License Type
Prebook Now
Request Customization
Speak to Analyst
Speak to Analyst
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
  • What are the Known and Unknown Adjacencies Impacting the Cytology Brush Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
©2024 MarketsandMarkets Research Private Ltd. All rights reserved Protection Status Website Feedback